Richard Schlenker
Analyst · William Blair & Company
Thanks, Paul. During the quarter, revenues before reimbursements or net revenues, as I will refer to them from here on, increased 4% to $66.5 million as compared to $64.2 million in the prior year period. Total revenues for the quarter were $71.9 million as compared to $73.5 million in 2011. This decline in total revenues is the result of a $3.8 million less of Technology Development product sales and $2.2 million less of reimbursable expenses in Technology Development.
Net income for the first quarter increased 2% to $8.2 million or $0.57 per diluted share. EBITDA in the quarter increased 3% to $14.8 million. We are pleased with these modest levels of growth considering the high hurdle created by an unusually strong performance in defense technology development in the first quarter of 2011.
During the first quarter of 2011, we had 2 large contributions from Technology Development, the first being significant surveillance system product sales and the second being a substantial amount of reimbursable expenses for the U.K. GPR project. As a result, net revenues for Tech Dev in the first quarter were $4.4 million, including $860,000 of product sales. This compares to net revenues of $6.5 million and $2.5 million in product sales in the same period 1 year ago.
Looking forward, we expect net revenues from product sales in the second quarter to be approximately $200,000 as compared to $100,000 in the second quarter of 2011. For the full year of 2012, we expect net revenues from product sales to be approximately the same as we had for the full year of 2011.
As Paul discussed, utilization in the first quarter was strong at 74% compared to 73% in the same quarter last year. Contributing to strong utilization was a 7% increase in billable hours, totaling $263,000.
Our average technical full-time equivalent employees increased 6% to 686 from 650 in the same period last year. We continue to selectively hire talent to expand our capabilities. For 2012, we expect sequential quarterly growth of FTEs to be approximately 1% per quarter.
During the first quarter of 2012, we realized an average billing rate increase of approximately 2.5% over the prior year. This was a result of new billing rate which took effect on January 1. We expect to realize a billing rate increase of about 2.5% for the full year as well.
The percentages I will reference hereafter are on a percentage of net revenue basis. EBITDA margin for the first quarter was 22.3% as compared to 22.5% in the first quarter last year. We are pleased to have held this within 20 basis points as a result of the increased utilization and effective cost management to offset last year's high Technology Development product sales and handling fees on the extra materials.
For the first quarter, compensation expense after adjusting for gains, losses and deferred compensation increased 6% to $44.7 million. This increase is the result of a 6% headcount growth. Included in total compensation in the first quarter is a gain in deferred compensation of $1.5 million as compared to $650,000 in the same quarter last year. As a reminder, deferred compensation gains and losses are offset in miscellaneous income and have no impact on the bottom line.
Additionally, our annual salary increases took effect at the beginning of April, and the overall increase is in line with the billing rate increases mentioned before.
As a component of compensation, stock-based compensation expense for the first quarter was $4.5 million. This is higher in the first quarter when we grant stock as part of our annual bonus payout. For 2012, we expect stock-based compensation to be approximately $11.5 million.
Other operating expenses for the first quarter decreased 3% over the prior year to $5.6 million. As a component of other operating expense, depreciation was $1.1 million. For the remainder of the year, we expect other operating expenses to be in the range of $6 million to $6.5 million per quarter.
G&A expenses in the first quarter decreased 13% to $2.9 million compared to $3.3 million in the same quarter last year. We expect G&A expense to be in the range of $3.1 million to $3.4 million in the next 2 quarters and then approximately $3.8 million in the fourth quarter.
Interest income in the first quarter was $77,000. Our tax rate for the first quarter of 2012 was 40.3% as compared to 40.2% in the same period last year. For 2012, we expect our tax rate to remain approximately 40.3%.
Turning to the balance sheet. Cash, cash equivalents and short-term investments were $103.7 million as compared to $109.7 million at the end of the fourth quarter. As expected, cash was down at the end of the first quarter following bonus payout in March. Additionally, we repurchased $4 million of common stock in the quarter and still have approximately $40.4 million available for stock repurchase and plan to actively repurchase shares during 2012.
Capital expenditures for the first quarter were $1.3 million. DSOs were 88 days at the end of the quarter.
For the first quarter -- the first quarter was a solid start to fiscal 2012 from which we have continued to expect growth in revenues before reimbursements in the low- to mid-single digits. This growth has been tempered by the fact that our largest projects in 2011 accounted for a greater percentage of our revenues than in a typical year. We expect these projects will step down in their level of activity over the next several quarters. As a result, we expect 2012 utilization to be lower by a percentage point or 2 as compared to last year, and EBITDA margins will be down slightly.
Now I will turn the call back to Paul for concluding remarks.